Potential for Excellagen in Repair of Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells

Cardium Reports On Potential Use Of Excellagen To Repair Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells (via PR Newswire)

Download image Logo. (PRNewsFoto/Cardium Therapeutics) SAN DIEGO, Aug. 12, 2013 /PRNewswire/ — Cardium Therapeutics (NYSE MKT: CXM) today reported on a research collaboration with researchers at Boston Children’s Hospital, to assess the medical utility…